Study shows breast cancer drug may cause diabetes
Oct 6, 2011
A new study published in the journal Cancer found that there is a direct link from the breast cancer drug tamoxifen and diabetes in certain women, according to Reuters.
The researchers studied 14,000 breast cancer patients over the age of 65, and 10 percent of those who took the drug developed diabetes within five years. However, there are a number of things that the researchers believe need to be studied further. These statistics should not alarm patients, but it is something they should be aware of, according to the news source.
The researchers are also adamant about breast cancer patients continuing to take the drug, as there are many benefits that outweigh the risks. In addition, the number of risks including increased likelihood of stroke, blood clots and cataracts, the media outlet reports.
According to the American Cancer Society, one in eight women in the U.S. will eventually be diagnosed with breast cancer at some point during their lifetime. It is the second most common form of cancer among women following skin cancer.